Insight -Unilever’s US$68bil toothpaste tilt needs another squeeze

Unilever’s offer may be in the ballpark, but the consumer-goods giant can justify stretching further – and could easily be forced to.

GLAXOSMITHKLINE Plc is right to snub Unilever Plc’s £50bil (US$68bil or RM284bil) proposal to buy the UK drugmaker’s consumer healthcare arm.

Unilever’s offer may be in the ballpark, but the consumer-goods giant can justify stretching further – and could easily be forced to.